RemeGen Co., Ltd. (SHA:688331)
China
· Delayed Price · Currency is CNY 48.90
+3.44 (7.57%)
May 13, 2025, 3:00 PM CST
RemeGen Revenue
RemeGen had revenue of 525.97M CNY in the quarter ending March 31, 2025, with 59.17% growth. This brings the company's revenue in the last twelve months to 1.91B, up 53.59% year-over-year. In the year 2024, RemeGen had annual revenue of 1.72B with 58.54% growth.
Revenue (ttm)
1.91B
Revenue Growth
+53.59%
P/S Ratio
11.73
Revenue / Employee
637.68K
Employees
2,999
Market Cap
22.43B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| WuXi AppTec | 39.59B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
| Aier Eye Hospital Group | 21.81B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Shanghai United Imaging Healthcare | 10.43B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |